For Institutional Investors & Family Offices

Meridian Strategic Advisors provides pre-vetted deal flow in healthcare innovation. We connect institutional capital with pharmaceutical and medical device companies that have passed rigorous screening.

What You Get

Access to healthcare companies at every stage of development that have been comprehensively evaluated across six criteria:

Management integrity and capability
IP ownership and freedom to operate
Financial sustainability and realistic capital needs
Operational capability to execute development timeline
Clear regulatory pathway to FDA approval
Ethical standards and genuine patient benefit

Every company we present has been properly positioned for institutional investment. We eliminate months of sorting through unqualified deals.

Our Standards

We work with a limited number of companies at any given time. Companies that don't meet our standards don't advance, regardless of how promising the technology appears.

We only work with founders who believe healthcare is a human right and are building technology that genuinely improves patient outcomes.

How It Works

First conversation is always face-to-face or via Zoom. We discuss your investment criteria, focus areas, and deal flow preferences.

We introduce opportunities that match your specific requirements. No noise. No wasted time. Only companies that merit your attention.

Who We Work With

We work with a limited number of clients at any given time. Every company passes comprehensive due diligence before we agree to represent them. Companies that don't meet our standards don't advance, regardless of how promising the technology appears.

We only work with founders who believe healthcare is a human right and are building technology that genuinely improves patient outcomes.

For institutional investors and family offices, this means pre-vetted deal flow in healthcare innovation. Companies that have been rigorously screened and properly positioned for capital deployment, saving you months of sorting through unqualified pitches.

We take equity in every engagement because we only succeed when the technology reaches patients.

Our Focus Areas

We work with companies developing breakthrough technologies across multiple therapeutic areas and medical specialties.

Our experience spans oncology treatments, autoimmune disease therapies, cardiovascular devices, neurological disorder treatments, diagnostic technologies, and surgical innovations.